ConCallIQ
Go Pro
ASHOKLEY Diversified 07 Aug 2025

Ashok Leyland Limited — Q1 FY26

Ashok Leyland delivered a record Q1 with revenue of ₹8,725 crore (+1.5% YoY) and PAT of ₹594 crore (+13% YoY), driven by market share gains (M&HCV at 31.1%, LCV at 12.9%), premiumization, and cost controls.

bullish high
Compare with...
Revenue ₹8,725 Cr +1.5%
EBITDA ₹970 Cr +6.4%
PAT ₹594 Cr +13%
EBITDA Margin 11.1% +50bps
Duration 45 min
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

Ashok Leyland delivered a record Q1 with revenue of ₹8,725 crore (+1.5% YoY) and PAT of ₹594 crore (+13% YoY), driven by market share gains (M&HCV at 31.1%, LCV at 12.9%), premiumization, and cost controls. EBITDA margin expanded 50bps to 11.1% despite steel cost pressures and mandatory AC introduction, which was fully passed on. Domestic M&HCV volumes grew 2% despite industry decline, while exports surged 29%. The defense order book stands at ₹1,000+ crore with a ₹2,000+ crore tender pipeline. Management expects mid-single-digit industry growth and margin uptrend in H2, supported by new product launches (high-horsepower trucks, LCV, buses) and capacity expansion. Key risk: replacement demand remains elusive despite favorable macro tailwinds.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Replacement demand not materializing

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

M&HCV Market Share (ex-defense & EVs) 31.1%
+130bps YoY

Improved from 29.8% in Q1 FY25, driven by premiumization and service excellence.

LCV Market Share (Wahan) 12.9%
+120bps YoY

Gained 120bps YoY, reflecting strong traction in the LCV segment.

Export Volume 3,111 units
+29% YoY

Strong growth led by GCC (60%+ growth), with UAE plant running at capacity.

Switch India Order Book 1,500+ buses
N/A

Switch India achieved PBT breakeven in Q1; order book supports FY26 EBITDA-positive target.

Fast read

Guidance and risk preview

Top guidance Mid-single-digit domestic M&HCV industry growth in FY26

Management expects mid-single-digit growth for M&HCV and slightly higher for LCV, with H2 likely stronger due to low base and improving macro.

Top risk Replacement demand not materializing

Despite aging fleet and favorable macro, replacement demand has not translated into volume growth, posing a risk to volume assumptions.

View Risks →